Avidity Biosciences, Inc. ( RNA) - Key Metrics
Stock symbol RNA is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker RNA was renamed to
RNAM
effective 2026-02-26.
RNA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0.01 | -$1.72 | -$1.23 | -$1.27 |
| 2025Q3 | $0.09 | -$1.27 | -$1.13 | -$1.16 |
| 2025Q2 | $0.03 | -$1.21 | -$1.54 | -$1.57 |
| 2025Q1 | $0.01 | -$0.90 | -$0.97 | -$0.99 |
| 2024Q4 | $0.02 | -$0.80 | -$0.78 | -$0.81 |
RNA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | -10.47 |
| 2025Q3 | ? | -8.61 |
| 2025Q2 | ? | -5.85 |
| 2025Q1 | ? | -8.24 |
| 2024Q4 | ? | -9.14 |
RNA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | -1.76% | ? |
| 2025Q3 | -2.66% | ? |
| 2025Q2 | -5.51% | ? |
| 2025Q1 | -3.37% | ? |
| 2024Q4 | -2.78% | ? |
RNA
Price: $13.21
52 week price:
Earnings Per Share: -4.48 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 810900
Market Capitalization: 229.9 million